The Institut Pasteur

Also on record

Records under this name other than the patents The Institut Pasteur holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 157 patents it holds.

Back to The Institut Pasteur

Patent	Title	Status	Expires	Confidence
US 9,636,395	Medicaments and Methods for Treating Mesothelioma now held by Centre National de la Recherche Scientifique In force Term ends Oct 10, 2028 · Medium confidence	In force	Term ends Oct 10, 2028	Medium confidence
US 9,056,071	Compounds and Methods for Preventing or Treating a Viral Infection now held by Astremiha Therapeutics In force Term ends Oct 31, 2028 · High confidence	In force	Term ends Oct 31, 2028	High confidence
US 9,833,492	Combinations of a Caspase Inhibitor and an Antiviral Agent now held by Astremiha Therapeutics In force Term ends Oct 31, 2028 · High confidence	In force	Term ends Oct 31, 2028	High confidence
US 9,023,643	Medicaments and Methods for Treating Mesothelioma now held by Centre National de la Recherche Scientifique In force Term ends Mar 8, 2030 · High confidence	In force	Term ends Mar 8, 2030	High confidence
US 8,821,851	Inflammation-Inhibitory Serum Factors and Uses Thereof now held by The General Hospital Corporation In force Term ends Sep 18, 2030 · High confidence	In force	Term ends Sep 18, 2030	High confidence
US 10,899,799	Method for Preparing Multiple Antigen Glycopeptide Carbohydrate Conjugates now held by Centre National de la Recherche Scientifique In force Term ends Jun 22, 2033 · Medium confidence	In force	Term ends Jun 22, 2033	Medium confidence
US 9,655,961	Recombinant Measles Virus Expressing Chikungunya Virus Polypeptides and Their Applications now held by Merck Sharp & Dohme LLC In force Term ends Sep 26, 2033 · High confidence	In force	Term ends Sep 26, 2033	High confidence
US 10,376,593	Glycoconjugates and Their Use as Potential Vaccines Against Infection by Shigella Flexneri now held by Université Paris Cité In force Term ends Oct 29, 2033 · High confidence	In force	Term ends Oct 29, 2033	High confidence
US 12,077,829	Anellovirus Genome Quantification as a Biomarker of Immune Suppression now held by Université Paris Cité In force Term ends Nov 8, 2033 · High confidence	In force	Term ends Nov 8, 2033	High confidence
US 10,144,975	Anellovirus Genome Quantification as a Biomarker of Immune Suppression now held by Université Paris Cité In force Term ends Nov 30, 2033 · High confidence	In force	Term ends Nov 30, 2033	High confidence

10 of 555 records shown.

Pro members see all 555.

Pro members: see all 555 records